Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gastrointestinal and mucosal microbiota-host immune system ecosystem represents the complex, bidirectional interaction between the trillions of microorganisms inhabiting the gut and the host's immune apparatus (Belkaid & Hand, 2014, Cell). This ecosystem is fundamental for maintaining physiological homeostasis, as the microbiota provides essential signals for the maturation and regulation of immune cells, particularly within the gut-associated lymphoid tissue (Thursby & Juge, 2017, Biochem J). Commensal bacteria influence the differentiation of T-cell subsets, such as regulatory T cells (Tregs) and Th17 cells, which are critical for balancing tolerance and inflammation (Round & Mazmanian, 2009, Nat Rev Immunology). Dysregulation of this delicate balance, often termed dysbiosis, is linked to a wide array of pathologies, including inflammatory bowel disease, allergies, and metabolic disorders (Lynch & Pedersen, 2016, NEJM). Therapeutic interventions targeting this ecosystem aim to restore balance through the use of probiotics, prebiotics, or fecal microbiota transplantation, rather than inhibiting a single molecular pathway. Understanding this system at an ecosystem level is crucial for developing holistic treatments that address the root causes of chronic inflammatory conditions.
Modulation of microbial composition and metabolite production (e.g., short-chain fatty acids) to regulate host immune cell differentiation and barrier integrity (Belkaid & Hand, 2014, Cell).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal and mucosal microbiota and host immune system cells at the ecosystem level.